Literature DB >> 9989284

Evidence for the formation of a novel cyclopentenone isoprostane, 15-A2t-isoprostane (8-iso-prostaglandin A2) in vivo.

Y Chen1, W E Zackert, L J Roberts, J D Morrow.   

Abstract

A2/J2-Isoprostanes (IsoPs) are prostaglandin (PG) A2/J2-like compounds that are produced in vivo as dehydration products of D2/E2-IsoPs. One A2-IsoP that should be formed is 15-A2t-IsoP (8-iso-PGA2). Analogous to cyclopentenone PGs, 15-A2t-IsoP readily undergoes nucleophilic addition to various biomolecules suggesting the compound is capable of exerting potent bioactivity. However, proof that it is definitively formed in vivo is lacking. Evidence is now presented that 15-A2t-IsoP, in fact, is generated in vivo by demonstrating that an endogenous A2-IsoP with a retention time on capillary GC identical with that 15-A2t-IsoP co-chromatographs through four high resolving HPLC purification procedures with authentic radiolabeled 15-A2t-IsoP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989284     DOI: 10.1016/s0005-2760(98)00168-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.

Authors:  Erik S Musiek; Rebecca S Breeding; Ginger L Milne; Giuseppe Zanoni; Jason D Morrow; Bethann McLaughlin
Journal:  J Neurochem       Date:  2006-04-21       Impact factor: 5.372

Review 2.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

Review 3.  Isoprostane generation and function.

Authors:  Ginger L Milne; Huiyong Yin; Klarissa D Hardy; Sean S Davies; L Jackson Roberts
Journal:  Chem Rev       Date:  2011-08-18       Impact factor: 60.622

Review 4.  Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.

Authors:  Erik S Musiek; Ginger L Milne; BethAnn McLaughlin; Jason D Morrow
Journal:  Brain Pathol       Date:  2005-04       Impact factor: 6.508

5.  Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury.

Authors:  Stephanie L H Zeiger; Erik S Musiek; Giuseppe Zanoni; Giovanni Vidari; Jason D Morrow; Ginger J Milne; BethAnn McLaughlin
Journal:  Free Radic Biol Med       Date:  2009-08-19       Impact factor: 7.376

6.  Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1.

Authors:  Serena Materazzi; Romina Nassini; Eunice Andrè; Barbara Campi; Silvia Amadesi; Marcello Trevisani; Nigel W Bunnett; Riccardo Patacchini; Pierangelo Geppetti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

Review 7.  Electrophilic cyclopentenone isoprostanes in neurodegeneration.

Authors:  Erik S Musiek; Bethann McLaughlin; Jason D Morrow
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

8.  Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products.

Authors:  Anna-Liisa Levonen; Aimee Landar; Anup Ramachandran; Erin K Ceaser; Dale A Dickinson; Giuseppe Zanoni; Jason D Morrow; Victor M Darley-Usmar
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 9.  Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.

Authors:  Jochen Bauer; Anne Ripperger; Stefan Frantz; Süleyman Ergün; Edzard Schwedhelm; Ralf A Benndorf
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 10.  Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases.

Authors:  Elżbieta Miller; Agnieszka Morel; Luciano Saso; Joanna Saluk
Journal:  Oxid Med Cell Longev       Date:  2014-04-29       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.